Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04773782
Title	A Study of Avapritinib in Pediatric Patients With Solid Tumors Dependent on KIT or PDGFRA Signaling
Recruitment	Active, not recruiting
Gender	both
Phase	Phase Ib/II
Variant Requirements	Yes
Sponsors	Blueprint Medicines Corporation
Indications	low grade glioma Advanced Solid Tumor high grade glioma
Therapies	Avapritinib
Age Groups:	child
Covered Countries	USA \| ITA \| GBR \| FRA \| DEU \| CAN \| AUT \| AUS